We are pleased to share an important milestone in the ESCO Natural History Study!! We have officially enrolled our very first NHS […]

Eight countries across Europe came together this September for STXBP1 Awareness Month, uniting to raise awareness of STXBP1-related disorders and

In September, following the heartbreaking news of the passing of the first participant in the Capsida CAP-002 SYNRGY clinical trial,

From October 8–11, 2025, Heidelberg became the center of the STXBP1 community, welcoming scientists, clinicians, families, and advocates from across

On April 8, The Dutch BRAINmodel project organized a parent panel meeting on potential future gene therapies for STXBP1-related disorders

Over the past several months, the STXBP1 community in the Netherlands has taken on an incredible challenge — kick starting

We are thrilled to announce that Prof. Dr. Matthijs Verhage, head of the department of Functional Genomics and a founder of the European STXBP1

We are excited to share a major milestone for the STXBP1 community: Capsida Biotherapeutics has received FDA clearance to begin

Rare Disease Month, culminating in Rare Disease Day on February 28 this year, is an important time for the rare